export const PersonLists = [
  {
    id: 1,
    name: 'Nahum Sonenberg, PhD',
    desc: 'Scientific Advisory Board Chair',
    image: require('@/assets/images/team/teams1.png'),
  }, {
    id: 2,
    name: 'Poul Sorensen, MD, PhD',
    desc: 'Scientific Advisory Board Member',
    image: require('@/assets/images/team/teams2.png'),
  }, {
    id: 3,
    name: 'Savvas G. Hatzikiriakos, PhD ',
    desc: 'Academic Research Collaborator',
    image: require('@/assets/images/team/teams3.png'),
  }, {
    id: 4,
    name: 'Minnie Liu, MD, PhD',
    desc: 'Scientific Research Collaborator',
    image: require('@/assets/images/team/teams4.png'),
  }
]

export const StudiesLists = [
  {
    id: 1,
    name: 'RECOMBINANT PROTEIN EXPRESSION',
    sepcialName: "Recombinant \nProtein expression",
    desc: 'Our protein expression platform encompasses three widely utilized systems: Escherichia coli (E. coli), yeast, and mammalian cells.',
    picture: require('@/assets/images/labs/lab1.png'),
    pictureWhite: require('@/assets/images/labs/lab-white1.png'),
  }, {
    id: 2,
    name: 'ANTIBODY DEVELOPMENT',
    sepcialName: "Antibody \ndevelopment",
    desc: "Our antibody platform comprises traditional hybridoma-based monoclonal antibody (mAb) development and a bi-specific antibody engineering platform.",
    picture: require('@/assets/images/labs/lab2.png'),
    pictureWhite: require('@/assets/images/labs/lab-white2.png'),
  }, {
    id: 3,
    name: 'MODELING & EXPERIMENTATION',
    sepcialName: "Modeling & \nexperimentation",
    desc: 'Our diverse modeling systems encompass proprietary reporter cell line models, conditionally regulated and stable cell lines, iPSC cell-derived 3D organoid models, syngeneic mouse tumor models, patient-derived xenograft (PDX) models, and transgenic mouse models.',
    picture: require('@/assets/images/labs/lab3.png'),
    pictureWhite: require('@/assets/images/labs/lab-white3.png'),
  }, {
    id: 4,
    name: 'MICROORGANISM-BASED CLEANTECH',
    sepcialName: "Microorganism - \nbased cleantech",
    desc: "By employing natural selection and genetic editing methodologies, we've developed a microbial-based platform. Through this, we've acquired highly proficient bioplastic-producing bacteria capable of utilizing industrial wastes (such as glycerin, fructose, and volatile fatty acids) as feedstock to yield high-volume bioplastic materials.",
    picture: require('@/assets/images/labs/lab4.png'),
    pictureWhite: require('@/assets/images/labs/lab-white4.png'),
  }, {
    id: 5,
    name: 'EXTRACTION & ANALYTICS',
    sepcialName: "Extraction & \nanalytics",
    desc: "We have developed a technology platform tailored for the extraction and isolation of bioactive phytochemicals from diverse botanical sources, with a particular emphasis on cruciferous species. This platform is complemented by a high-performance liquid chromatography (HPLC) analytical system, enabling precise identification and quantitative analysis of targeted phytochemical constituents.",
    picture: require('@/assets/images/labs/lab5.png'),
    pictureWhite: require('@/assets/images/labs/lab-white5.png'),
  }, {
    id: 6,
    name: 'DRUG DELIVERY',
    sepcialName: "Drug \ndelivery",
    desc: "We have devised polymer-based and chitosan-based methodologies for the formulation of nanomedicines, facilitating their targeted delivery to specific microenvironments. Furthermore, our drug formulation and delivery platforms empower us to engineer premium-grade nutraceutical and cosmeceutical products characterized by superior stability and bioavailability.",
    picture: require('@/assets/images/labs/lab6.png'),
    pictureWhite: require('@/assets/images/labs/lab-white6.png'),
  }
]